Adverse Ocular Effects of Systemic Medications
MB Green, JS Duker - Life, 2023 - mdpi.com
While ocular complications of systemic medications are uncommon, it is important to
recognize that vision-threatening toxicities can occur. This review details the vision …
recognize that vision-threatening toxicities can occur. This review details the vision …
[PDF][PDF] 半量睫状体光凝术对青光眼患者生活质量及血清Endothelin-1 水平的影响
蒋晨, 万新娟, 谢小东, 刘琪, 丁琳 - Age (years), 2022 - biomed.cnjournals.com
摘要目的: 探究半量睫状体光凝术对青光眼患者生活质量及血清内皮素(ET-1) 水平的影响. 方法:
选择2018 年4 月至2021 年4 月于我院接受治疗的80 例(80 眼) 青光眼患者为研究对象 …
选择2018 年4 月至2021 年4 月于我院接受治疗的80 例(80 眼) 青光眼患者为研究对象 …
Internistische Erkrankungen und Zusammenhang mit dem primären Offenwinkelglaukom
AM Voigt, S Grabitz, EM Hoffmann… - Klinische …, 2024 - thieme-connect.com
Primary open-angle glaucoma is a neurodegenerative disease with progressive chronic
optic neuropathy and corresponding visual field defects. In this literature review, we discuss …
optic neuropathy and corresponding visual field defects. In this literature review, we discuss …
The effect of Calcium channel blocker in the Betamethasone-induced Glaucoma model in rabbits
WK Abdulsahib, SJ Abood - Journal of Advanced Pharmacy Education and …, 2021 - japer.in
Abstract To Evaluate the Ocular-hypotensive Effect of Levamlodipine in the Betamethasone-
induced Glaucoma Model in the Rabbits. Ocular-hypertension was made by weekly …
induced Glaucoma Model in the Rabbits. Ocular-hypertension was made by weekly …
Medication Induced Glaucoma
M Mansoor, I Nwokeji, LM Provencher - Current Ophthalmology Reports, 2023 - Springer
Purpose To discuss current definitions, pathophysiology, diagnosis, and management of
medication-induced glaucoma. Recent Findings Treatment of steroid-induced glaucoma …
medication-induced glaucoma. Recent Findings Treatment of steroid-induced glaucoma …
[PDF][PDF] Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy. Polymers 2022, 14, 2359
Glaucoma is extensively treated with topical eye drops containing drugs. However, the
retention time of the loaded drugs and the in vivo bioavailability of the drugs are highly …
retention time of the loaded drugs and the in vivo bioavailability of the drugs are highly …
Клинические особенности развития и прогрессирования первичной открытоугольной глаукомы у пациентов с отягощенным семейным анамнезом
ИА Булах, ПЧ Завадский, СН Ланин… - Национальный …, 2023 - glaucomajournal.ru
Аннотация ЦЕЛЬ. Определение клинико-эпидемиологических особенностей развития
прогрессирования первичной открытоугольной глаукомы (ПОУГ) у пациентов с …
прогрессирования первичной открытоугольной глаукомы (ПОУГ) у пациентов с …
Corticotrophins, corticosteroids, and prostaglandins
E Samuel, D Fakharzadeh, B Prophete, SD Ray… - Side Effects of Drugs …, 2021 - Elsevier
In this chapter, we have reviewed side effects reported for corticotrphins, systemic
glucocorticoids, and prostaglandin analogues from January 2020 to June 2021. We used …
glucocorticoids, and prostaglandin analogues from January 2020 to June 2021. We used …
Neuroprotektive Wirkungen von Antidiabetika in der Therapie von Patienten mit Diabetes und Glaukom oder hohem Glaukomrisiko
B Weisser, C Erb - Klinische Monatsblätter für Augenheilkunde, 2024 - thieme-connect.com
There is an association between glaucoma and several risk factors and metabolic diseases,
such as type 2 diabetes mellitus. Diabetes mellitus leads to neurodegenerative changes …
such as type 2 diabetes mellitus. Diabetes mellitus leads to neurodegenerative changes …